Bioxcel Therapeutics
BTAIQ · US
Held by 1 big investorsLargest: Oaktree
Bioxcel Therapeutics is held by 1 of the 26 tracked investors in their latest 13F filings. The largest position is Oaktree Capital Management's at $1.9M, 0.03% of that portfolio.
Big investors holding this stock
Latest 13F of the 26 tracked investors. Common shares only.
| Investor | Value ($) | vs prior quarter |
|---|---|---|
| Oaktree Capital Management weight 0.03% · Q2 2026 |
1.9M | ▲ 472% |
Holding history
13F · shares at each quarter-endShares (1 investors)Investors holding
| Investor | 5 quarters | Latest shares | vs prior quarter |
|---|---|---|---|
| Oaktree | 1.4M | ▲472.3% |
Shares are split-adjusted to today. A quarter with no filing on record carries the previous value in the mini line.
Key points
- Holders
- Oaktree Capital Management ($1.9M), per their latest 13F filings.
- Berkshire
- Berkshire Hathaway did not report it in its latest 13F.
- Note
- Not in its latest 13F.
Discussion
sign in to join · no buy/sell tipsLoading…
Restated and computed from SEC (13F, 13D/G, Form 4) and DART filings and NPS public data. Filings describe a past date and may differ from current holdings (13F: quarter end, up to 45 days later). Not investment advice.
Sources: SEC EDGAR, DART, data.go.kr (NPS), OpenFIGI. See Methodology for how figures are computed.